Á¶È¸¼ö
|
18253
|
Á¦¸ñ
|
2022.12 ÀÓÇüÁØ ±³¼ö, ´ëÇѳª³ëÀÇÇÐȸ Ãß°èÇмú´ëȸ Âü¿©
|
2022³â 12¿ù 10ÀÏ, ´ëÇѳª³ëÀÇÇÐȸ ÁÖ°ü Ãß°èÇмú´ëȸ°¡ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÇコÄɾîÇõ½ÅÆÄÅ©¿¡¼ °³ÃֵǾú´Ù. À̹ø Çмú´ëȸÀÇ ÁÖÁ¦´Â "Recent progressive nanotechnology for future imaging and therapy"·Î, nanotechnology¸¦ °Á¶ÇÏ¿´´Ù. °¿¬Àº ¼¼ °¡Áö ¼¼¼ÇÀ¸·Î ÁøÇàµÇ¾ú°í, ³»¿ëÀº ´ÙÀ½°ú °°´Ù.- Nanotechnology in medical diagnostics and imaging- Nanotechnology in targeted therapy- Nanotechnology in cancer immunotherapy ÀÓÇüÁØ ±³¼ö´Â Nanotechnology in medical diagnostics and imaging session¿¡ Âü¿©ÇÏ¿©, TMTLab¿¡¼ ÁøÇàµÈ ¿¬±¸µéÀ» ¼Ò°³Çß´Ù. ¿¬±¸ ³»¿ëÀº ´ÙÀ½°ú °°´Ù.- Radiolabeled Europium loaded Nanoparticle for Radioisotope induced Photodynamic Therapy- Theranostic liposome coated Au-Liposome for effective tumor targeting and photothermal therapy- Development of spleen targeting H2S donating liposome for therapeutic immunomodulation in colitis model- Spatial Transcriptomics-Based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue On December 10, 2022, the Autumn Academic Conference organized by the Korean Society Nanomedicine was held at Seoul National University Bundang Hospital Healthcare Innovation Park.The theme of this conference was "Recent progressive nanotechnology for future imaging and therapy," which emphasized nanotechnology.The lecture was conducted in three sessions, and the contents are as follows.- Nanotechnology in medical diagnostics and imaging- Nanotechnology in targeted therapy- Nanotechnology in cancer immunotherapyProfessor Hyung-Jun Im participated in the Nanotechnology in medical diagnostics and imaging session and introduced the studies conducted in TMTLab. The contents of the study are as follows.- Radiolabeled Europium loaded Nanoparticle for Radioisotope induced Photodynamic Therapy- Theranostic liposome coated Au-Liposome for effective tumor targeting and photothermal therapy- Development of spleen targeting H2S donating liposome for therapeutic immunomodulation in colitis model- Spatial Transcriptomics-Based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue
|
|
|
|